Pharmacia Is “Recidivist” On GMPs, FDA Says After Two Warnings In 5 Years
Executive Summary
FDA considers two GMP warning letters issued to the same plant more than five years apart to be evidence that a company is "recidivist" on compliance issues, the agency told Pharmacia